Pages that link to "Q46406532"

The following pages link to Clioquinol inhibits the proteasome and displays preclinical activity in leukemia and myeloma (Q46406532):

Displaying 33 items.

• Nitroxoline (8-hydroxy-5-nitroquinoline) is more a potent anti-cancer agent than clioquinol (5-chloro-7-iodo-8-quinoline) (Q24632516) (← links)
• 8-Hydroxyquinolines: a review of their metal chelating properties and medicinal applications (Q28389539) (← links)
• The ubiquitin-activating enzyme E1 as a therapeutic target for the treatment of leukemia and multiple myeloma (Q33523956) (← links)
• Tumor cellular proteasome inhibition and growth suppression by 8-hydroxyquinoline and clioquinol requires their capabilities to bind copper and transport copper into cells (Q33622430) (← links)
• Clioquinol induces pro-death autophagy in leukemia and myeloma cells by disrupting the mTOR signaling pathway (Q33918007) (← links)
• Quinoline-based clioquinol and nitroxoline exhibit anticancer activity inducing FoxM1 inhibition in cholangiocarcinoma cells (Q35410253) (← links)
• Pharmacological activity of metal binding agents that alter copper bioavailability (Q35587484) (← links)
• The ubiquitin-proteasomal system is critical for multiple myeloma: implications in drug discovery (Q35824929) (← links)
• Interplay between Structure and Charge as a Key to Allosteric Modulation of Human 20S Proteasome by the Basic Fragment of HIV-1 Tat Protein (Q35843506) (← links)
• The role of allostery in the ubiquitin-proteasome system (Q36721779) (← links)
• The antiparasitic clioquinol induces apoptosis in leukemia and myeloma cells by inhibiting histone deacetylase activity (Q37333839) (← links)
• Current treatment options for Dientamoeba fragilis infections. (Q37390538) (← links)
• Methyl groups as probes of supra-molecular structure, dynamics and function (Q37604187) (← links)
• Interferon-stimulated gene 15 induces cancer cell death by suppressing the NF-κB signaling pathway (Q37688501) (← links)
• Copper is a potent inhibitor of both the canonical and non-canonical NFκB pathways. (Q37698887) (← links)
• Novel proteasome inhibitors to overcome bortezomib resistance (Q37878771) (← links)
• Copper complexes as therapeutic agents (Q37970312) (← links)
• Induction of cell cycle arrest via the p21, p27-cyclin E,A/Cdk2 pathway in SMMC-7721 hepatoma cells by clioquinol (Q38811018) (← links)
• Structural characterization and biological evaluation of a clioquinol-ruthenium complex with copper-independent antileukaemic activity (Q39500218) (← links)
• Novel clioquinol and its analogous platinum complexes: importance, role of the halogen substitution and the hydroxyl group of the ligand. (Q39110246) (← links)
• Gluconjugates of 8-hydroxyquinolines as potential anti-cancer prodrugs (Q39392617) (← links)
• Clioquinol induces cytoplasmic clearance of the X-linked inhibitor of apoptosis protein (XIAP): therapeutic indication for prostate cancer. (Q39572385) (← links)
• High cytotoxicity of dihalo-substituted 8-quinolinolato-lanthanides (Q39604034) (← links)
• Cyclic AMP efflux inhibitors as potential therapeutic agents for leukemia. (Q39809596) (← links)
• Supramolecular synthon pattern in solid clioquinol and cloxiquine (APIs of antibacterial, antifungal, antiaging and antituberculosis drugs) studied by 35Cl NQR, 1H-17O and 1H-14N NQDR and DFT/QTAIM (Q41969878) (← links)
• Characterization of clioquinol and analogues as novel inhibitors of methionine aminopeptidases from Mycobacterium tuberculosis (Q42723485) (← links)
• Novel mitochondria targeted copper(ii) complexes of ferrocenyl terpyridine and anticancer active 8-hydroxyquinolines showing remarkable cytotoxicity, DNA and protein binding affinity. (Q46449120) (← links)
• Development of a copper-clioquinol formulation suitable for intravenous use. (Q48106957) (← links)
• Proteasome inhibitor clioquinol as a candidate drug in prophylaxis and treatment of acute graft-versus-host disease (Q82692897) (← links)
• Repurposing Drugs for Acute Myeloid Leukemia: A Worthy Cause or a Futile Pursuit? (Q89761769) (← links)
• Restoration of susceptibility to amikacin by 8-hydroxyquinoline analogs complexed to zinc (Q92374519) (← links)
• A Proteomic View of Cellular Responses to Anticancer Quinoline-Copper Complexes (Q93017778) (← links)
• A combination of clioquinol, zinc and copper increases the abundance and function of breast cancer resistance protein in human brain microvascular endothelial cells (Q93257503) (← links)